3644 results for «2816»

Filter By

3644 results

New evidence in the PFO closure

21 May 2025 – From EuroPCR 2025

Gain new insights into patent foramen ovale (PFO) closure with this session exploring age-related outcomes, risk of atrial arrhythmia, and patient selection improvements. Review various imaging approaches for assessing residual shunts and compare guidance techniques including TEE, fluoroscopy, and intracardiac echo from recent clinical registries.

New evidence in the PFO closure

Complex multivessel disease - LIVE Case

21 May 2025 – From EuroPCR 2025

An 89-year-old male patient presented with stable angina, preserved LV function and some risk factors such as hypertension and diabetes. CT scan and angiography revealed occlusion of proximal RCA and bifurcation lesions on LAD and circumflex (medina 1,1,1). Operators treated the bifurcation lesions with provisional stenting.
Regarding...

Complex multivessel disease - LIVE Case

LAA closure and anthrombotic therapies

21 May 2025 – From EuroPCR 2025

Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.

LAA closure and anthrombotic therapies

Which valve is best for my patient?

21 May 2025 – From EuroPCR 2025

This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.

Which valve is best for my patient?

Coronary scaffolds: new developments and applications

21 May 2025 – From EuroPCR 2025

Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.

Coronary scaffolds: new developments and applications

Current DCB practice: from lesion preparation to follow-up

21 May 2025 – From EuroPCR 2025

Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.

Current DCB practice: from lesion preparation to follow-up

Mitral TEER in challenging scenarios - Part 2

21 May 2025 – From EuroPCR 2025

This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.

Mitral TEER in challenging scenarios - Part 2

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI

TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3

21 May 2025 – From EuroPCR 2025

Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.

TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3

Complication management during mitral TEER procedures

21 May 2025 – From EuroPCR 2025

Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.

Complication management during mitral TEER procedures

How are we going to treat these sick patients presenting with pulmonary embolism?

21 May 2025 – From EuroPCR 2025

Address the urgent clinical question of how to treat patients presenting with pulmonary embolism across varying risk profiles. This session covers risk stratification and discusses interventional treatment options through detailed case analyses of intermediate and high-risk patients, providing practical guidance for individualized management.

How are we going to treat these sick patients presenting with pulmonary embolism?

Beyond angiography: imaging-guided solutions for stent failure

22 May 2025 – From EuroPCR 2025

Stent failure remains a critical challenge in interventional cardiology — but intracoronary imaging can change the outcome. This session goes beyond angiography to examine why stents fail, how to detect underlying causes, and how imaging-guided strategies can help tailor reintervention. Two real-life cases, from complex restenosis...

Beyond angiography: imaging-guided solutions for stent failure

Improving outcomes of NSTEMI patients

21 May 2025 – From EuroPCR 2025

Review contemporary evidence on improving outcomes for NSTEMI patients. Topics include the effects of evolocumab on stent coverage, impact of left ventricular function with kidney disease, GRACE score-based outcomes, PCI timing, and early initiation of Tafolecimab.

Improving outcomes of NSTEMI patients

Calcium modification: contemporary comparaisons of atherectomy and IVL

22 May 2025 – From EuroPCR 2025

Compare contemporary calcium modification techniques including atherectomy and intravascular lithotripsy (IVL) in complex coronary lesions. Review clinical outcomes, procedural case studies, and registry data highlighting safety and efficacy in acute coronary syndrome and high-risk patients.

Calcium modification: contemporary comparaisons of atherectomy and IVL

Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously

21 May 2025 – From EuroPCR 2025

This session evaluates right heart catheterisation and cardiac CT imaging in the assessment of percutaneously treated atrioventricular valves. Explore clinical outcomes, invasive physiology characterization, annular remodeling, and pulmonary hypertension impact on mitral and tricuspid valve interventions.

Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously

Challenging clinical scenarios in coronary artery disease

21 May 2025 – From EuroPCR 2025

Confront challenging clinical scenarios in coronary artery disease with case-based discussions. Topics include managing multiple stent layers, late mediastinal hematoma, PCI optimization through physiology and imaging, refractory angina treatment, and acute tamponade management.

Challenging clinical scenarios in coronary artery disease

Hotline TAVI 3: Challenging anatomical and clinical scenarios

22 May 2025 – From EuroPCR 2025

This hotline session presents challenging anatomical and clinical scenarios in TAVI, including outcomes in bicuspid aortic valve patients, chronic aortic regurgigation, comparisons of surgical versus percutaneous approaches, and real-world data on valve performance and resource utilization.

Inludes:

  • Five-year outcomes from the Evolut low risk TAVR bicuspid study
  • Surgical versus...
Hotline TAVI 3: Challenging anatomical and clinical scenarios

Therapeutic choices for TTVIV-TTVIR interventions

21 May 2025 – From EuroPCR 2025

Explore therapeutic choices for transcatheter tricuspid valve-in-valve and valve-in-ring interventions. Case studies cover annular ring expansion, pacing-related infection, jugular vein access valve replacement, Ebstein anomaly, and double valve-in-valve procedures in right heart disease.

Therapeutic choices for TTVIV-TTVIR interventions

Hypertension interventions in specific scenarios

22 May 2025 – From EuroPCR 2025

Explore interventions for hypertension in specific patient populations, including renal artery stenosis treatment and the role of renal denervation. Discuss multidisciplinary approaches and evidence supporting renal denervation in advanced kidney disease, heart failure, and young patients.

Hypertension interventions in specific scenarios

Mitral TEER in challenging scenarios - Part 3

21 May 2025 – From EuroPCR 2025

This session focuses on challenging mitral TEER cases, including papillary muscle rupture post-myocardial infarction, advanced heart failure treatment, emerging therapies for mitral regurgitation, and novel percutaneous repair techniques.

Mitral TEER in challenging scenarios - Part 3
Didn’t find what you were looking for?